Uveitis Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are being treated for an immune-mediated inflammatory disease (a condition where the immune system causes inflammation) at one of the participating departments at Lille University Hospital (dermatology, internal medicine, neurology, lung care, or rheumatology)
- You are covered by social insurance (confirm with trial site)
- You are able to understand what the study involves, agree to take part in writing, and follow the study's data collection process
Who may not be able to join:
- You are unable to receive or understand information about the study, cannot participate for the full duration, or are not covered by the social security system
- You are currently pregnant or breastfeeding
- You are currently detained or deprived of your liberty
- You are a minor or an adult who is under legal protection (confirm with trial site)
- You are unable to give your informed consent, or you have chosen not to
- You are currently in an emergency medical situation
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: David Launay, MD,PhD, University Hospital, Lille
Phone: 03 20 44 42 95
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change of SLEDAI for lupus; Change of Medsger score; Change of EDSS for multiple sclerosis; Change of BASDAI for psoriatic arthristis; Change of Longhurst criteria for hereditary angioedema; Change of number of flares for atopic dermatitis; Change of number of exacerbations for severe asthma; Change of 12-Item Short-Form Health Survey (SF-12) - quality of life scale; number of participant with severe infectious events
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.